Results 111 to 120 of about 4,764 (176)

Finerenone Across the Cardiovascular-Kidney-Metabolic Continuum: From Mechanistic Rationale to Clinical Positioning-A Narrative Review. [PDF]

J Clin Med
Kubica J, Kubica A, Ratajczak J, Gajda R, Szarpak Ł, Navarese EP.   +5 more
europepmc   +1 more source

Pulsed field ablation for atrial fibrillation in patients with heart failure: insight from the ATHENA registrys. [PDF]

Europace
Schiavone M, Solimene F, Dello Russo A, Bianchi S, Iacopino S, Malacrida M, Rossillo A, Themistoclakis S, Bertini M, Meynet I, Moltrasio M, Schillaci V, Casella M, Bisignani A, Colella J, Russo M, Volpicelli M, Bandino S, Zingarini G, Mitacchione G, Casula M, Fassini G, Rordorf R, De Sanctis V, De Simone A, Rovaris G, Zucchelli G, Tondo C.   +27 more
europepmc   +1 more source

Amino Acid-Derived Metabolic Signature Across Stages of Systolic Dysfunction: Derivation and Internal Evaluation of the HASI (Heart Failure Amino Acid-Derived Systolic Index)-40 Index. [PDF]

Int J Mol Sci
Krasińska B, Spasenenko I, Pietkiewicz D, Plewa S, Filipiak KJ, Pawlaczyk-Gabriel K, Bartkowski J, Tykarski A, Krasiński Z, Matysiak J, Urbanowicz T.   +10 more
europepmc   +1 more source

Predicting ICU admission in geriatric hip fracture patients with heart failure: the role of O-POSSUM and heart failure subtypes. [PDF]

BMC Geriatr
Bayındır S, Kazez M, Yalın M.
europepmc   +1 more source

Heart Failure With Mildly Reduced Ejection Fraction: A Call for a Precision Medicine Approach. [PDF]

JACC Adv
Wu L, Rizwan A, Rodriguez M, El Hachem K, Hassan Virk HU, Khawaja M, Strauss M, Krittanawong C.   +7 more
europepmc   +1 more source

HFrEF, HFmrEF, and HFpEF: Are They a Continuum or Different Faces of a Syndrome?

International Journal of Cardiovascular Sciences
Even Edilce Mol, Camila Hartmann, Lídia Ana Zytynski Moura   +2 more
openaire   +2 more sources

Epicardial adipose tissue as a determinant of heart failure prognosis: insights across ejection fraction phenotypes. [PDF]

Cardiovasc Diabetol
Nowakowski M, Mazuruk M, Nogajski Ł, Mączewski M, Czerwińska H, Kurpias M, Mączewski M, Paterek A.   +7 more
europepmc   +1 more source

Development and Validation of a Prognostic Model to Predict Mortality in Patients With Heart Failure With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction. [PDF]

Cardiol Res
Liu ZC, Zhang LL, Peng L, Zeng JP, Jiang MY.   +4 more
europepmc   +1 more source

Differential cardiovascular benefits of SGLT2 inhibitors, sacubitril/valsartan, omecamtiv mecarbil, and vericiguat across heart failure phenotypes: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Wang M, Zuo Z, Wu T, Zhou Z.
europepmc   +1 more source

Treatment with finerenone in people with heart failure and mildly reduced or preserved ejection fraction: a plain language review. [PDF]

Future Cardiol
Bains M, Butt JH, Ostrominski JW, Pabon Porras MA, Humphreys-Davies L.   +4 more
europepmc   +1 more source